Apollo Global Management vs Franklin Templeton
APO and BEN side by side, both in services allied with the exchange of securities. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How APO and BEN compare
Apollo Global Management is the larger company, worth 4.3 times as much as Franklin Templeton ($68.4B against $16.1B).
On earnings, Franklin Templeton is cheaper: it trades at 21.5× trailing earnings, against 42.0× for Apollo Global Management.
Apollo Global Management grew revenue faster over the last twelve months (41.2% versus 7.9% for Franklin Templeton).
Franklin Templeton keeps more of each dollar of sales as profit, with a net margin of 8.7% compared with 5.2% at Apollo Global Management.
Both pay dividends: Apollo Global Management yields 1.9% and Franklin Templeton 4.2%.
Apollo Global Management scores higher on the StockData Score (11 against 9 for Franklin Templeton), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | APO | BEN |
|---|---|---|
| Size and price | ||
| Market cap | $68.4B | $16.1B |
| Share price | $115.84 | $31.64 |
| Change, 1 year | −7.2% | 37.9% |
| Change, 5 years | 50.6% | −11.8% |
| Beta (5Y) | 1.48 | 1.17 |
| Employees | 4,130 | 9,800 |
| StockData Score | ||
| Total score | 11 (better) | 9 |
| Valuation score | 2 (better) | 1 |
| Growth score | 2 (better) | 1 |
| Performance score | 1 (better) | 0 |
| Health score | 4 | 4 |
| Dividend score | 2 | 3 (better) |
| Valuation | ||
| P/E | 42.0× | 21.5× (better) |
| P/S | 1.9× | 1.7× (better) |
| P/B | 3.3× | 1.4× (better) |
| EV/EBITDA | 6.2× (better) | 13.1× |
| Fair value | $121.32 | $27.33 |
| Margin of safety | 4.5% (better) | −15.8% |
| Growth | ||
| Revenue growth (TTM) | 41.2% (better) | 7.9% |
| Revenue growth, 5Y average | 68.6% (better) | 9.5% |
| Net income growth (TTM) | −44.3% | 152% (better) |
| EPS growth (TTM) | −47.1% | 183% (better) |
| EPS growth, 5Y average | 66.0% (better) | −10.6% |
| Profitability | ||
| Operating margin | – | 9.7% |
| Net margin | 5.2% | 8.7% (better) |
| Return on equity | 9.3% (better) | 6.8% |
| Return on invested capital | – | 8.3% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Interest coverage | – | 10.2× |
| Altman Z-score | 0.18 | 1.23 (better) |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.9% | 4.2% (better) |
| Payout ratio | 67.8% | 85.4% |
| Years of dividend growth | 3 | 6 (better) |
| Dividend growth, 5Y average | −2.9% | 3.5% (better) |
| Buyback yield | 1.9% | 3.2% (better) |
| Shareholder yield | 3.8% | 7.4% (better) |
| Ownership | ||
| Held by institutions | 65.6% | 53.6% |
| Held by insiders | 23.9% | 21.0% |
| Insider net buying, 12 months | −$9.8M | $2.1M (better) |
| Superinvestors holding | 4 | – |
| Short interest, % of float | – | 4.6% |
Go deeper
- APO stock overview
- APO income statement
- APO valuation and score
- BEN stock overview
- BEN income statement
- BEN valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.